Glass House Brands Inc. Announces Voting Results Following Annual and Special Meeting
At the Meeting, all eight nominees for the Board of Directors of the Company were elected, the voting results of which are as follows:
Note:
Shareholders also approved the re-appointment of Macias Gini & O'Connell LLP as auditors of the Company for the ensuing year, authorized the directors to fix the auditors' remuneration, and approved a one-time fixed increase to the rolling 10% share reserve under the Company's long-term equity incentive plan and the granting of performance awards thereunder. Of the votes cast by shareholders entitled to vote thereon, the auditors' reappointment was approved with a 99.99% favorable vote and the vote for the long-term incentive plan achieved 97.85% approval.
Full details of the foregoing are contained in the Report of Voting Results for the Meeting which has been filed on SEDAR+ at
www.sedarplus.ca
.
About Glass House Brands
Glass House
is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. From its greenhouse cultivation operations to its manufacturing practices, from brand-building to retailing, the Company's efforts are rooted in the respect for people, the environment, and the community that co-founders
Kyle Kazan
, Chairman and CEO, and
Graham Farrar
, Board Member and President, instilled at the outset. Whether it be through its portfolio of brands, which includes
Glass House Farms
,
PLUS Products
,
Allswell
and Mama Sue Wellness or its network of retail dispensaries throughout the state of California, which includes
The Farmacy
,
Natural Healing Center
and
The Pottery
, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, visit
www.glasshousebrands.com/
and
https://ir.glasshousebrands.com/contact/email-alerts/
.
Forward Looking Statements
This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as 'forward-looking statements'). Forward-looking statements reflect current expectations or beliefs regarding future events or the Company's future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward- looking statements can be identified by the use of words such as 'plans', 'expects', 'is expected', 'budget', 'scheduled', 'estimates', 'continues', 'forecasts', 'projects', 'predicts', 'intends', 'anticipates', 'targets' or 'believes', or variations of, or the negatives of, such words and phrases or state that certain actions, events or results 'may', 'could', 'would', 'should', 'might' or 'will' be taken, occur or be achieved. Forward-looking statements in this news release include, without limitation, statements regarding the Company's financial outlook or operational plans and statements related to future market conditions. All forward-looking statements, including those herein, are qualified by this cautionary statement. Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. Accordingly, readers should not place undue reliance on forward-looking statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including those risks disclosed in the Company's Annual Information Form available on SEDAR+ at
www.sedarplus.ca
and in the Company's Form 40-F available on EDGAR at
www.sec.gov
. For more information on the Company, investors are encouraged to review the Company's public filings on SEDAR+ at
www.sedarplus.ca
. The forward-looking statements in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
For further information, please contact:
Glass House Brands Inc.
Jon DeCourcey, Vice President of Investor Relations
T: (781) 724 6869
E:
ir@glasshousebrands.com
Investor Relations Contact:
KCSA Strategic Communications
Phil Carlson
T: 212-896-1233
E:
GlassHouse@kcsa.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
20 minutes ago
- The Hill
UnitedHealth acknowledges DOJ investigation into Medicare billing
UnitedHealth Group confirmed Thursday that the company is facing both criminal and civil investigations from the Department of Justice (DOJ) related to its Medicare billing practices. The health care giant said in a securities filing and subsequent statement it has begun complying with formal criminal and civil requests. UnitedHealth's stock was also down a little under 4 percent on Thursday. 'The Company has a long record of responsible conduct and effective compliance,' UnitedHealth said in its filing. 'Independent CMS audits confirm that the Company's practices are among the most accurate in the industry, and, following a decade-long civil challenge by the Department to aspects of our Medicare Advantage business, a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing.' UnitedHealth said it has launched its own initiative to conduct third party reviews of 'policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' The disclosure marks the first time the company has acknowledged the existence of any DOJ investigations, and it comes after a series of Wall Street Journal articles in recent months brought the details to light. The company said it 'proactively' reached out to the DOJ after reviewing media reports about the agency's investigations. The Journal reported in February that DOJ launched a civil investigation into whether the company inflated diagnoses to trigger extra payments to its Medicare Advantage (MA) plans, which are privately run insurance plans reimbursed by the federal government. The outlet first reported on the criminal Medicare fraud probe in May. UnitedHealth is the largest insurer in the MA market. Thursday's announcement comes ahead of its second-quarter earnings call on July 29 and could mark a shift in strategy under new CEO Stephen Hemsley, who took over in May after Andrew Witty suddenly stepped down. The company has experienced a tumultuous year that included suspending its 2025 earnings forecast, partly due to higher medical costs for new MA plan enrollees.
Yahoo
2 hours ago
- Yahoo
UnitedHealth confirms federal investigation into its Medicare practices
UnitedHealth Group confirmed Thursday that its Medicare program is under investigation by the US Department of Justice and that it is working with the agency. The health insurer, which has been in upheaval since the murder of one of its top executives late last year, said in a statement it reached out to the Justice Department after media reports about the investigations. 'The Company has now begun complying with formal criminal and civil requests from the Department,' it said. 'The Company has full confidence in its practices and is committed to working cooperatively with the Department throughout this process.' The Justice Department is investigating UnitedHealth for potential criminal fraud in its Medicare Advantage program, the Wall Street Journal reported in May. The company is one of a number of insurers that the federal government contracts with to provide Medicare coverage to senior citizens and other enrollees. UnitedHealth reiterated on Thursday that it has launched third-party reviews of various policies and practices, including the codes it uses to evaluate patients' health status, its managed care practices and its pharmacy services. The investigation is the latest crisis for the nation's top insurer, which is also one of America's biggest corporations. The CEO of its health insurance unit, Brian Thompson, was gunned down on a New York City sidewalk in December, which unleashed a torrent of angry social media posts about care denials by UnitedHealth and other insurers. Andrew Witty, its former CEO, stepped down abruptly in May, shortly after the company suspended its financial outlook for the year, citing continued higher-than-expected costs in its Medicare Advantage program. UnitedHealth's former longtime CEO, Stephen Hemsley, has returned to lead the company. UnitedHealth's (UNH) stock has lost about half its value over the past year – more than $277 billion. It was down about 3.6% in late morning trading Thursday. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
2 hours ago
- Business Wire
Offerpad Solutions Inc. Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement
TEMPE, Ariz.--(BUSINESS WIRE)--Offerpad Solutions Inc. ("Offerpad") (NYSE: OPAD), a leading tech-enabled platform for residential real estate, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 2,857,143 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $2.10 per share ('the Registered Offering'). The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million. Share In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,428,571 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.30 per share, will be exercisable commencing six months from the date of issuance, and will expire four years following the initial exercise date. The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million, before deducting placement agent fees and other estimated offering expenses. The Company expects to use the net proceeds from the Offerings for general working capital. A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offerings. The Registered Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-270994) previously filed with the U.S. Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of the proposed Offering will be filed with the SEC and will be available on the SEC's website located at Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@ The private placement of the Common Warrants and the shares underlying the Common Warrants offered to the institutional investor will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). Accordingly, the securities issued in the concurrent private placements may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Offerpad Offerpad, dedicated to simplifying the process of buying and selling homes, is a publicly traded company committed to providing comprehensive solutions that remove the friction from real estate. Our advanced real estate platform offers a range of services, from consumer cash offers to B2B renovation solutions and industry partnership programs, all tailored to meet the unique needs of our clients. Since 2015, we've leveraged local expertise in residential real estate alongside proprietary technology to guide homeowners at every step. #OPAD_IR Forward-Looking Statements This release contains 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as 'believes,' 'expects,' 'anticipates,' 'intends,' 'will,' 'may,' 'should,' or similar expressions. These forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering and uncertainties related to the size, timing, completion, and use of proceeds from the proposed offering. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the Company's business in general, please refer to the Company's prospectus supplement to be filed with the SEC, and the documents incorporated by reference therein, including the Company's Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company has no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise.
